http://www.otonomy.com
Otonomy, Inc. Company Intro
Hearing, balance and connection—all easy to take for granted, but profoundly impactful when disrupted. Disorders of the ear are often associated with feelings of frustration, decreased social interaction and depression. At Otonomy, our focus is on making new treatments a reality for the millions living with the debilitating, daily impact of these conditions.
Industry
Healthcare
Otonomy, Inc. Headquaters
4796 Executive Drive
San Diego,92121
United States
Otonomy, Inc. Share price
22 Jan 2021 02:18 GMT
$4.9000
0.04 (0.82 %)
Otonomy, Inc. Market cap
$226.67 M
WMC RANKING
2021
Otonomy, Inc. # 277
BiotechnologyLatest Otonomy, Inc. News
11 Jan 2021
Is Otonomy Inc (OTIC) Stock a Great Value?
Otonomy Inc (OTIC) stock is up 58.60% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver's proprietary ...
11 Jan 2021
Is Otonomy Inc (OTIC) Stock a Great Value?
Otonomy Inc (OTIC) stock is up 58.60% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver's proprietary ...
11 Jan 2021
Is Otonomy Inc (OTIC) Stock a Great Value?
Otonomy Inc (OTIC) stock is up 58.60% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver's proprietary ...
WMC Market Score
WMC Market to Revenue Score
Otonomy, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Otonomy, Inc. | USD | $600 | $44,495 | $-44,675 | $2,267M | 277 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,243,500 | $5,152,600 | $3,156,000 | $571,390B | 1 |
| Alexion Pharmaceuticals, Inc. | USD | $5,862,400 | $2,588,400 | $956,600 | $345,270B | 2 |
| Vertex Pharmaceuticals Incorporated | USD | $5,991,128 | $2,596,854 | $2,690,691 | $620,550B | 3 |
| ALK-Abello A/S | USD | $3,383,000 | $1,831,000 | $43,000 | $271,640B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Otonomy, Inc. Social Followers vs Top 4 Industry Competitors
Otonomy, Inc. Post vs Top 4 Industry Competitors
Otonomy, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Otonomy, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Otonomy, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Otonomy, Inc. | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Regeneron Pharmaceuticals, Inc. | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Alexion Pharmaceuticals, Inc. | 100 | 100 | 100 | 0 | 0 | 0 | 100 |
| Vertex Pharmaceuticals Incorporated | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| ALK-Abello A/S | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
